Can you provide the upcoming earnings date for CUMBERLAND PHARMACEUTICALS?
CUMBERLAND PHARMACEUTICALS (CPIX) will report earnings on 2026-05-04.
CUMBERLAND PHARMACEUTICALS (CPIX) Forecast, Price Target & Analyst Ratings
NASDAQ:CPIX • US2307701092
Current stock price
3.05 USD
+0.22 (+7.77%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CUMBERLAND PHARMACEUTICALS (CPIX).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $3.05 to mean target of N/A, Based on 6 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
CPIX was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about CPIX.
In the previous month the buy percentage consensus was at a similar level.
CPIX was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 4, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 39.553M -5.85% | 37.868M -4.26% | 44.521M 17.57% | |
| EBITDA YoY % growth | -1.275M -1,134.74% | -1.53M -20.00% | 1.353M 188.46% | |
| EBIT YoY % growth | -6.211M -19.33% | -6.432M -3.57% | -2.792M 56.59% | |
| Operating Margin | -15.70% | -16.99% | -6.27% | |
| EPS YoY % growth | 0.18 | -0.08 -144.44% | 0.11 237.50% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
CUMBERLAND PHARMACEUTICALS / CPIX Forecast FAQ
What is the consensus rating for CUMBERLAND PHARMACEUTICALS (CPIX) stock?
The consensus rating for CUMBERLAND PHARMACEUTICALS (CPIX) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.